Koninklijke Philips PE Ratio 2010-2024 | PHG
Current and historical p/e ratio for Koninklijke Philips (PHG) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Koninklijke Philips PE ratio as of January 31, 2025 is 19.63.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Koninklijke Philips PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-01-31 | 27.58 | 1379.00 | |
| 2024-09-30 | 32.72 | $0.02 | 1636.00 |
| 2024-06-30 | 25.20 | $-0.21 | 0.00 |
| 2023-06-30 | 20.97 | $-0.68 | 0.00 |
| 2023-03-31 | 16.99 | $-0.52 | 0.00 |
| 2022-06-30 | 19.93 | $0.58 | 34.36 |
| 2021-06-30 | 44.27 | $0.60 | 73.78 |
| 2020-06-30 | 40.97 | $0.85 | 48.20 |
| 2019-06-30 | 35.97 | $1.32 | 27.25 |
| 2018-06-30 | 34.07 | $1.47 | 23.18 |
| 2017-06-30 | 28.24 | $1.98 | 14.26 |
| 2016-12-31 | 23.51 | $1.71 | 13.75 |
| 2016-09-30 | 22.76 | $0.94 | 24.21 |
| 2016-06-30 | 19.18 | $0.87 | 22.05 |
| 2016-03-31 | 21.19 | $0.69 | 30.71 |
| 2015-12-31 | 18.89 | $0.78 | 24.22 |
| 2015-09-30 | 17.41 | $1.00 | 17.41 |
| 2015-06-30 | 18.90 | $0.48 | 39.37 |
| 2015-03-31 | 20.38 | $0.51 | 39.96 |
| 2014-12-31 | 20.85 | $0.60 | 34.75 |
| 2014-09-30 | 22.80 | $1.03 | 22.14 |
| 2014-06-30 | 22.84 | $1.59 | 14.36 |
| 2014-03-31 | 24.43 | $1.68 | 14.54 |
| 2013-12-31 | 25.69 | $1.69 | 15.20 |
| 2013-09-30 | 22.41 | $0.57 | 39.31 |
| 2013-06-30 | 18.89 | $0.39 | 48.44 |
| 2013-03-31 | 19.81 | $0.16 | 123.78 |
| 2012-12-31 | 17.79 | $0.29 | 61.34 |
| 2012-09-30 | 15.72 | $0.58 | 27.10 |
| 2012-06-30 | 13.18 | $0.45 | 29.30 |
| 2012-03-31 | 12.95 | $-1.76 | 0.00 |
| 2011-12-31 | 13.33 | $-1.91 | 0.00 |
| 2011-09-30 | 11.42 | $-1.02 | 0.00 |
| 2011-06-30 | 16.34 | $-0.42 | 0.00 |
| 2011-03-31 | 19.84 | $1.91 | 10.38 |
| 2010-12-31 | 18.93 | $2.01 | 9.42 |
| 2010-09-30 | 19.31 | $1.75 | 11.03 |
| 2010-06-30 | 18.40 | $1.31 | 14.04 |
| 2010-03-31 | 19.74 | $1.04 | 18.98 |
| 2009-12-31 | 17.63 | $0.66 | 26.72 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $25.642B | $19.663B |
| Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.767B | 27.38 |
| Boston Scientific (BSX) | United States | $151.377B | 43.52 |
| Stryker (SYK) | United States | $149.082B | 32.08 |
| EssilorLuxottica (ESLOY) | France | $125.055B | 0.00 |
| Medtronic (MDT) | Ireland | $117.214B | 17.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.950B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.139B | 28.03 |
| GE HealthCare Technologies (GEHC) | United States | $40.136B | 20.82 |
| ResMed (RMD) | United States | $37.119B | 30.50 |
| Terumo (TRUMY) | Japan | $28.886B | 41.07 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.107B | 14.07 |
| Insulet (PODD) | United States | $19.438B | 77.40 |
| Baxter (BAX) | United States | $16.737B | 10.89 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.084B | 40.57 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.966B | 33.87 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.433B | 14.95 |
| ICU Medical (ICUI) | United States | $4.121B | 39.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.893B | 19.36 |
| Envista Holdings (NVST) | United States | $3.678B | 27.40 |
| Haemonetics (HAE) | United States | $3.430B | 16.74 |
| Perrigo (PRGO) | Ireland | $3.366B | 9.91 |
| GN Store Nord (GNNDY) | Denmark | $3.027B | 19.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.927B | 18.84 |
| Neogen (NEOG) | United States | $2.495B | 28.75 |
| LeMaitre Vascular (LMAT) | United States | $2.247B | 54.60 |
| AtriCure (ATRC) | United States | $2.067B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.464B | 25.63 |
| InMode (INMD) | Israel | $1.462B | 8.79 |
| AdaptHealth (AHCO) | United States | $1.430B | 10.22 |
| BioLife Solutions (BLFS) | United States | $1.313B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.270B | 0.00 |
| Owens & Minor (OMI) | United States | $1.150B | 8.99 |
| Evolus (EOLS) | United States | $0.922B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.887B | 15.64 |
| CeriBell (CBLL) | United States | $0.833B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.830B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.649B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.561B | 24.73 |
| Surmodics (SRDX) | United States | $0.511B | 0.00 |
| Omeros (OMER) | United States | $0.502B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.429B | 0.00 |
| Valneva SE (VALN) | France | $0.412B | 0.00 |
| ZimVie (ZIMV) | United States | $0.401B | 33.77 |
| Quanterix (QTRX) | United States | $0.370B | 0.00 |
| Cerus (CERS) | United States | $0.360B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.322B | 30.67 |
| Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
| Biote (BTMD) | United States | $0.309B | 6.76 |
| OraSure Technologies (OSUR) | United States | $0.291B | 19.50 |
| Canopy Growth (CGC) | Canada | $0.265B | 0.00 |
| Zynex (ZYXI) | United States | $0.263B | 55.13 |
| High Tide (HITI) | Canada | $0.239B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.233B | 3.28 |
| Utah Medical Products (UTMD) | United States | $0.208B | 15.52 |
| Aurora Cannabis (ACB) | Canada | $0.203B | 0.00 |
| Brainsway (BWAY) | Israel | $0.197B | 104.70 |
| MacroGenics (MGNX) | United States | $0.190B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.154B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.27 |
| Quipt Home Medical (QIPT) | United States | $0.135B | 0.00 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Fonar (FONR) | United States | $0.102B | 11.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Exagen (XGN) | United States | $0.072B | 0.00 |
| INLIF (INLF) | $0.071B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.051B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.050B | 14.35 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |